Cullinan Oncology, Inc.·4

Mar 27, 4:05 PM ET

Jones Jeffrey Alan 4

4 · Cullinan Oncology, Inc. · Filed Mar 27, 2023

Insider Transaction Report

Form 4
Period: 2023-03-20
Jones Jeffrey Alan
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2023-03-20$11.32/sh390$4,41559,610 total
Footnotes (1)
  • [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION